ZLAB
Zai LabยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ZLAB Profile
Zai Lab Limited
A biotech company that develops and commercializes innovative oncology and autoimmune therapies in China and globally
Biological Technology
03/28/2013
09/20/2017
NASDAQ Stock Exchange
1,850
12-31
Depository Receipts (Ordinary Shares)
Building 1, 4/F, Jinchuang Plaza, 4560 Jinke Road, Pudong, Shanghai, PRC
Zai Lab Limited and its affiliates are committed to addressing the huge unmet medical needs in the fields of oncology, immunity, neuroscience and infectious diseases through the discovery, development and commercialization of innovative products.
Zai Lab Limited is a holding company mainly engaged in biopharmaceuticals. The company is committed to addressing unmet medical needs in oncology, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The company has a portfolio of patented drug candidates from the discovery stage to the later stages of clinical programs. These include "Zele", "OPTUNE", "Qingle", "New Zele" and "Weiweijia".
